1.
Mullokulov J., Akhmedov Kh., Anorboev M. HEAD-TO-HEAD COMPARATIVE EFFICACY OF GOLIMUMAB VS. TOFACITINIB IN REACTIVE ARTHRITIS: A 52-WEEK REAL-WORLD COHORT STUDY FROM UZBEKISTAN. CAJM. 2025;1(10):58-64. Accessed November 19, 2026. https://journals.tnmu.uz/index.php/cajm/article/view/3204